Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07126132) titled 'Hpx*apoB Product as a Biomarker for Coronary Artery Disease' on Aug. 10.

Study Type: Observational

Primary Sponsor: Shiyan City Renmin Hospital

Condition: Coronary Artery Disease

Intervention: Procedure: Coronary Angiography

Recruitment Status: Not recruiting

Date of First Enrollment: January 1, 2019

Target Sample Size: 460

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07126132

Published by HT Digital Content Services with permission from Health Daily Digest....